PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Shift to Phenotypic Assays Spurs Growth in High Content Screening Sector - Various factors, such as the need for high performance research technologies, the generation of information within a sample and the growing instances of diseases, all contribute to the growth in the high content screen (HCS) sector
Shift to Phenotypic Assays Spurs Growth in High Content Screening Sector

 

NewswireToday - /newswire/ - Palo Alto, CA, United States, 2007/09/17 - Various factors, such as the need for high performance research technologies, the generation of information within a sample and the growing instances of diseases, all contribute to the growth in the high content screen (HCS) sector.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

This development is furthered by the low instance of false positives and false negative results.

Frost & Sullivan's (ti.frost.com) study High Content Screening for Target Identification and Validation finds that even though HCS and conventional methods such as high throughput screening (HTS) execute similar functions, the inherent characteristics of HCS enables superior performances, thereby leading to HCS adoption. The current trend displays that most pharmaceutical and biotech institutions favor working with HCS in comparison to conventional methods, due to the unparalleled advantages that HCS produces.

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants an overview of the latest analysis of the High Content Screening for Target Identification and Validation, then send an email to Melina Trevino - Corporate Communications at melina.trevino[.]frost.com with the following information: your full name, company name, title, telephone number, email address, city, state, and country. We will send you the information via email upon receipt of the above information.

The ability to minimize errors is a critical driver in drug response. Drug response relates to whole cells with the presence of thousands of targets, instead of single targets, that aid in the instant identification of undesirable side effects.

These multiplexed HCS assays help in the measurement of multiple parameters within single cells. The calculation, analysis, and interpretation of the parameters for every single cell generates a variety of information simultaneously in the same sample. This is a critical driver as it enables sensing a drug’s toxicity and its side effects, in addition to its action.

"In addition to the shift from target-based assays to phenotypic assays, HCS offers the unique benefit of mining of primary images later as required for gaining additional information," explains Frost & Sullivan Research Analyst Meena Kannan "It further helps in identifying targets that cannot be evaluated by the use of HTS, such as translocation or sub cellular analysis of pathways and the analysis of multiple events within a cell at a single time."

Apart from these advantages, HCS meets the need for efficacious and speedy research tools, spurred by the fierce competition in the drug discovery industry and therapeutics sector.

However, despite increasing utilization of HCS, it must rise above the competition posed by conventional methods such as HTS and microfluidics. HCS promoters should work to overcome conventional mindsets of consumers reluctant to change existing systems. Publication of company innovations and developments to ensure that the information reaches the customers explaining its benefits and usefulness is necessary to promote HCS adoption and erase any consumer apprehensions.

Large initial investments required to change systems is another factor slowing the acceptance of HCS. "Companies must work toward creating platforms with greater competitive advantages and more economically viable through tactical partnerships and alliances," notes Kannan. "This move would enable more powerful distribution, marketing, and merging of research knowledge, creating more formidable products in the marketplace."

High Content Screening for Target Identification and Validation is part of the Technical Insights – Therapeutics and Clinical Diagnostics, which also includes research in the following application sectors: biotechnology, pharmaceutical and drug discovery, and therapeutics. Markets across Asia, North America, and Europe have been covered in this study. This research service provides a valuable overview by offering a synopsis of emerging technologies in HCS. It also includes a summary of key patents that will offer an insight into notable activities and important participants. All research services included in this subscription provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews are available for the press.

Technical Insights is an international technology analysis business that produces a variety of technical news alerts, newsletters, and research services.

About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective, and combines ongoing analysis of markets, technologies, econometrics, and demographics.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Shift to Phenotypic Assays Spurs Growth in High Content Screening Sector

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Melina Trevino 
210.247.2440 melina.trevino[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Thales Launches the Pixium Portable 3543 DR Wifi Enabled Flat Panel Detector
GE Healthcare Showcases Industry-first Technologies and Digital Solutions, Focused on Improving Outcomes, At RSNA 2016
Agfa and LCsys Team Up to Launch ABSOLUT-ID, Their Turnkey Integrated Solution for the Production of High Security ID Cards
ZOLL Technology for Improving CPR Quality to be Showcased at American Heart Association Annual Conference
AccuVein to Exhibit Leading Vein Visualization Technology at American Society for Dermatologic Surgery Annual Meeting
US Biomedical Textiles Transform Implant Device Technology by Aligning to Changes in Patient Preference Finds Frost & Sullivan
Frost & Sullivan Commends Influence Health for Constantly Evolving its Patient Engagement Products to Accelerate Market Transformation
Frost & Sullivan Awards Carestream Top Honors for OnSight 3D Extremity System
Sparta Systems Launches the Next-Generation Cloud Solution Stratas QMS
Koning Wins Accolades from Frost & Sullivan for the Impressive Innovation Behind its Groundbreaking KBCT Breast Imaging Device
Frost & Sullivan Awards ResMed for Developing S+ Advanced Sleep Tracking System
Sparta Systems Becomes First Quality Management Solutions Provider to Achieve EU-U.S. Privacy Shield Compliance
ZOLL Expands the Rescuer Experience at EMS World Expo
Agfa and GPMI Sign Distribution Agreement for Agfa’s Synthetic Paper Synaps
Frost & Sullivan Highlights iLine Microsystems for Developing a Microfluidics-Based Sophisticated POC Device for PT/INR Coagulation Testing

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Triggr & Bloom

Visit  NAKIVO, Inc.





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)